This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,009,800
The role of SHOC2 in KRAS mutant-driven cancers and development of novel pan-KRAS mutant inhibitors by targeting SHOC2
CIHR · 2025 · Nominated PI
- $478,000
Repurposing of FDA-approved drugs as novel therapeutics for COVID-19
CIHR · 2020 · Nominated PI
- $802,725
Targeting cellular aneuploidy through modulation of Ran GTPase in epithelial ovarian cancer
CIHR · 2016 · Co-investigator
The role of SHOC2 in KRAS mutant-driven cancers and development of novel pan-KRAS mutant inhibitors by targeting SHOC2
Principal investigators: Wu, Jian Hui
Keywords: Drug Resistance; Kras Mutant Inibitors; Kras Mutants; Nsclc; Pancreatic Cancer; Shoc2; Shoc2/Kras
Repurposing of FDA-approved drugs as novel therapeutics for COVID-19
Principal investigators: Wu, Jian Hui
Keywords: Binding-Site Matching; Bret2 Assays; Covid-19; Drug Repurposing; In Silico Screening; Inhibitor Of Rbd/Ace2; Mpro Inhibitors; Plpro Inhibitors
Targeting cellular aneuploidy through modulation of Ran GTPase in epithelial ovarian cancer
Principal investigators: Mes-Masson, Anne-Marie
Keywords: Aneuploidy; Cell Lines; Gene Silencing; Medicinal Chemistry; Mouse Xenografts; Ovarian Cancer; Ran Gtpase; Ran Inhibitors; Therapeutics
Development of novel pan-inhibitors of the androgen receptor variants as effective therapeutics for castration-resistant prostate cancer
Principal investigators: Wu, Jian Hui
Keywords: Androgen Receptor; Antiandrogen; Ar-V7; Castration-Resistant Prostate Cancer; N-Terminal Domain
Novel strategy to selectively target tumor cell growth and chemosensitivity
Principal investigators: Batist, Gerald
Keywords: Keap1; P13kinase; Selective Chemosensitization; Therapeutic Resistance; Transcriptional Protein Nrff2
Novel bifunctional antiandrogens that suppress oncogenic activation of the androgen receptor in castration-resistant prostate cancer
Principal investigators: Wu, Jian Hui
Keywords: Androgen Receptor; Antiandrogen; Castration-Resistant Prostate Cancer; Ikk; Mutation
Chemical inhibitors of androgen receptor splice variants lacking the ligand-binding domain as novel agents for castration-resistant prostate cancer
Principal investigators: Wu, Jian Hui
Keywords: Androgen Receptor; Antiandrogen; Ar Variant Lacking The Lbd; Castration-Resistant Prostate Cancer; Chemical Optimization; Inhibitor Of Ar Variant
The CIHR/FRSQ Training Program in Cancer Research at McGill
Principal investigators: Tremblay, Michel L; Miller, Wilson H
Keywords: Cancer Research; Collaborative; Ethics; Multidisciplinary Program; Scientific Management; Training; Translational Research
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.